Talphera (TLPH) Shares Outstanding (Weighted Average) (2010 - 2026)
Talphera (TLPH) recorded quarterly Shares Outstanding (Weighted Average) of $69.8 million in Q1 2026, up 77.58% quarter-over-quarter from $39.3 million in Q4 2025, and up 165.8% on a YoY basis from $26.3 million in Q1 2025.
Talphera (TLPH) Shares Outstanding (Weighted Average) (2010 - 2026) Analysis & Trends
Talphera's Shares Outstanding (Weighted Average) history runs 17 years deep, the most recent figure standing at $69.8 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Weighted Average) rose 165.8% year-over-year to $69.8 million; the TTM figure through Mar 2026 stood at $69.8 million (up 165.8% YoY), while the FY2025 annual figure was $42.4 million, up 43.89% from the prior year.
- Shares Outstanding (Weighted Average) was $69.8 million for Q1 2026 at Talphera, up from $39.3 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $145.6 million in Q1 2022 to a low of $5.2 million in Q1 2023.
- Historically, Shares Outstanding (Weighted Average) has averaged $33.8 million across 5 years, with a median of $29.5 million in 2022.
- The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Weighted Average) surged 3234.82% in 2022, then tumbled 96.43% in 2023.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $29.5 million in 2022, then slipped by 26.44% to $21.7 million in 2023, then soared by 35.94% to $29.5 million in 2024, then soared by 33.4% to $39.3 million in 2025, then soared by 77.58% to $69.8 million in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $69.8 million (Q1 2026), $39.3 million (Q4 2025), and $40.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.16 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 422.10 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 43.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 5.02 Bn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 100.50 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 497.70 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 166.20 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 228.36 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 64.74 Mn |
| 10 | Talphera | 56.42 Mn | 56.42 Mn | - | 69.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 69.82 Mn |
| Dec 31, 2025 | 39.32 Mn |
| Sep 30, 2025 | 40.32 Mn |
| Jun 30, 2025 | 34.53 Mn |
| Mar 31, 2025 | 26.27 Mn |
| Dec 31, 2024 | 29.47 Mn |
| Sep 30, 2024 | 29.47 Mn |
| Jun 30, 2024 | 26.20 Mn |
| Mar 31, 2024 | 29.47 Mn |
| Dec 31, 2023 | 21.68 Mn |
| Sep 30, 2023 | 21.68 Mn |
| Jun 30, 2023 | 10.92 Mn |
| Mar 31, 2023 | 5.19 Mn |
| Dec 31, 2022 | 29.47 Mn |
| Sep 30, 2022 | 7.34 Mn |
| Jun 30, 2022 | 7.36 Mn |
| Mar 31, 2022 | 145.62 Mn |
| Dec 31, 2021 | 883,833.00 |
| Sep 30, 2021 | 5.86 Mn |
| Jun 30, 2021 | 119.12 Mn |